Cite
APA Citation
Agulnik, M., Schulte, B., Robinson, S., Hirbe, A. C., Kozak, K., Chawla, S. P., Attia, S., Rademaker, A., Zhang, H., Abbinanti, S., Cehic, R., Monga, V., Milhem, M., Okuno, S., & Van Tine, B. A. (2021). an open-label single-arm phase II study of regorafenib for the treatment of angiosarcoma. European journal of cancer, 154, 201–208. http://access.bl.uk/ark:/81055/vdc_100139915744.0x00003a